Secondhand exposure to vaping can cause serious respiratory issues - study

Innovation by THE JERUSALEM POST
May.31.2022
Secondhand exposure to vaping can cause serious respiratory issues - study
Although marketed as a safer alternative to cigarettes, vaping can still cause severe respiratory health issues in those repeatedly exposed to it.

Using an e-cigarette may not actually be that much safer than smoking a traditional cigarette and can still cause significant respiratory problems, both for smokers and those around them, new research published by the University of Southern California has found.

 

The use of e-cigarettes, known as vaping, is often marketed as a healthier alternative to traditional cigarette smoking, as they don’t contain tar, one of the main components of a traditional cigarette responsible for damaging the lungs. However, they still contain nicotine, the component that makes smoking addictive, and many other chemicals, all of which combine to create an aerosol that the user then inhales.

 

As more research is done surrounding the use of e-cigarettes, medical professionals are piecing together a picture of the harm that they can do. A new peer-reviewed study from the Department of Population and Public Health Science at the University of Southern California, LA, examines the impact that the secondhand smoke from vaping can cause.

 

Can respiratory symptoms develop as a result of secondhand vape exposure?

 

The study, entitled “Secondhand nicotine vaping at home and respiratory symptoms in young adults,” works to examine whether or not exposure to secondhand nicotine vape smoke is associated with adverse respiratory health symptoms among young adults.

 

In order to assess their objective, the research team, led by Prof. Talat Islam, examined data spanning a six-year period between 2014-2019 regarding the prevalence of bronchitis and shortness of breath in high-school students aged 17-18 years. In total, 2090 students participated in the study.

 

Conducting the study

 

During the first phase of the study in 2014, the students completed questionnaires detailing their exposure to vape smoke and their medical history. Then, three additional follow-up questionnaires were completed over the subsequent years, in 2015, 2017, and 2018.

 

However, of the original 2090 students, 23% left the study after the completion of high school and did not participate in any of the follow-up assessments. Nevertheless, the researchers note that the prevalence of secondhand nicotine vape exposure, bronchitic symptoms and shortness of breath did not differ substantially between those who left the study early and those who remained.

 

The respiratory symptoms measured were bronchitic symptoms such as wheezing and shortness of breath experienced in the last 12 months. If participants responded that they had experienced either bronchitis in the last year, a daily cough for three consecutive months, or congestion even when not accompanied by a cold, they were considered to have bronchitic symptoms.

 

Wheeze symptoms were based on a report of wheezing or whistling in the chest during the previous year, and shortness of breath was based on a report of having trouble breathing when hurrying on level ground or walking up a slight hill.

 

At each stage of the study, detailed information regarding secondhand exposure to e-cigarette aerosol, as well as cigarette smoke, was collected from the participants. Secondhand nicotine vape exposure was defined based on participants’ reports that anyone in their household, other than themselves, used e-cigarettes or other similar devices. Secondhand smoking exposure was defined based on reports of secondhand exposure to combustible tobacco.

 

Upon the completion of the data collection stages of the study, the research teamed turned to the statistical analysis portion of the research. They evaluated the association between secondhand nicotine vape exposure and respiratory symptoms at each stage of the study, adjusting as necessary to account for whether or not the participant themself smoked, ensuring that this would not skew the results of the study.

 

The results of the study

 

Following the analysis of the data, the research team discovered that the prevalence of secondhand nicotine vape exposure increased from 11.7% in 2014 to 15.6% in 2018, while the prevalence of secondhand smoking decreased from 26.6% to 20.6% in the same time period.

 

Over the study period, an increase in the prevalence of wheeze and bronchitic symptoms was observed in the study participants. Wheeze symptoms increased from 12.3% to 14.9%, while bronchitic symptoms increased from 19.4% to 26.0%. The prevalence of shortness of breath did not show any clear trend over time.

 

The data also showed a clear increase in respiratory symptoms in people who were exposed to secondhand nicotine vaping compared to people who were not. Compared with unexposed participants, participants with secondhand vape exposure were found to be 40% more likely to develop bronchitis symptoms and 53% to have shortness of breath symptoms, compared with participants who were not passively exposed to e-cigarettes.

 

Commenting on the study’s findings, the researchers state that to their knowledge, this is the first extended study-based report of the effects of secondhand nicotine vape exposure on respiratory symptoms among adolescents and young adults.

 

Source:THE JERUSALEM POST

Trump Administration Report: Vaping Designated as a Key Issue in the ‘Childhood Chronic Disease and Health Crisis’
Trump Administration Report: Vaping Designated as a Key Issue in the ‘Childhood Chronic Disease and Health Crisis’
The White House’s strategic report emphasizes that e-cigarettes are now a priority in addressing the “children’s health crisis.” The document states that vaping has become one of the key factors contributing to adolescent mental-health problems. The administration will task the Office of the Surgeon General with public education campaigns warning about the risks of alcohol, e-cigarettes, and THC; meanwhile, the Food and Drug Administration (FDA) and the Bureau of Alcohol, Tobacco, Firearms and E
Sep.10 by 2FIRSTS.ai
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
The US Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) for Imperial Tobacco’s blu® Disposable Classic Tobacco 2.4% e-cigarette, prohibiting its sale and distribution in the United States. FDA’s review found that the company’s Premarket Tobacco Product Application (PMTA) did not provide sufficient evidence to demonstrate that the product could help smokers fully switch to e-cigarettes or significantly reduce cigarette consumption. Instead, existing evidence suggested
Aug.20 by 2FIRSTS.ai
NJOY Sues FDA Over Delayed Ruling on Flavored Disposable Vapes
NJOY Sues FDA Over Delayed Ruling on Flavored Disposable Vapes
Altria’s subsidiary NJOY has sued the U.S. Food and Drug Administration (FDA) and the U.S. Department of Health and Human Services (HHS), alleging prolonged delays in ruling on its appeal for flavored disposable vapes. NJOY argues the products are identical to authorized versions and backed by scientific data and safeguards, yet the review has taken far beyond statutory limits, blocking lawful products while illicit ones flood the market.
Aug.24
IHit-HyperV Ceramic Atomization Technology Achieves Commercial Maturity, Redefining the New Standard for Visible E-liquid Pod Systems
IHit-HyperV Ceramic Atomization Technology Achieves Commercial Maturity, Redefining the New Standard for Visible E-liquid Pod Systems
At the 2025 CHAMPS Trade Show, iHit Tech (SMISS Group) announced the commercial maturity of its IHit-HyperV ceramic atomization technology. The breakthrough boosts efficiency and flavor performance, setting a new benchmark for visible e-liquid pod systems.
Sep.12
Texas Bans Most Disposable Vapes, Sparking Business and Health Concerns
Texas Bans Most Disposable Vapes, Sparking Business and Health Concerns
A new Texas law prohibiting the sale and marketing of most disposable e-cigarettes and THC vapes has taken effect, drawing criticism from retailers, consumers, and public health experts who warn it may fuel illegal markets and limit safer consumption options.
Sep.09
Product | OXBAR's new "Three-warehouse, Three-control" design with sweetness, coolness, and nicotine adjustment enters EU/US markets.
Product | OXBAR's new "Three-warehouse, Three-control" design with sweetness, coolness, and nicotine adjustment enters EU/US markets.
The new OXBAR e-cigarette TRI-FUSION has recently been launched on the official website. The product features three independent buttons that allow for the adjustment of sweetness, nicotine concentration, and coolness separately, and claims to offer 100 flavor combinations. Currently, the product is available on retail websites in the United States, the United Kingdom, and Canada.
Aug.29 by 2FIRSTS.ai